CoChat

Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience

Open access
Sanghani, Neil S., Haase, Volker H. · 2019 · Advances in Chronic Kidney Disease
Cited by 185

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Prolyl hydroxylase domain (PHD) oxygen sensors are dioxygenases that regulate the activity of hypoxia-inducible factor (HIF), which controls renal and hepatic erythropoietin (EPO) production and coordinates erythropoiesis with iron metabolism. Small molecule inhibitors of PHD dioxygenases (HIF-PHI) stimulate the production of endogenous EPO and improve iron metabolism resulting in efficacious anemia management in patients with chronic kidney disease. Three oral HIF-PHIs, daprodustat, roxadustat and vadadustat, have now advanced to global phase III clinical development culminating in the recent licensing of roxadustat for oral anemia therapy in China. Here, we survey current clinical experience with HIF-PHIs, discuss potential therapeutic advantages and deliberate over safety concerns regarding long-term administration in patients with renal anemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.ackd.2019.04.004

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

Metadata

Authors
Sanghani, N. S., & Haase, V. H.
Venue
Advances in Chronic Kidney Disease
Publisher
Elsevier BV
Published
2019-07
Volume
26
Issue
4
Pages
253-266
ISSN
1548-5595 (ISSN-L)
OpenAlex
W2970670654
Cited by
185
References
29
FWCI
16.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.